Shop

Brief Summary Taking in an amazing range of nationalities - British, Arabic, Chinese, Indian, Greek, Italian, American, Korean - in "Leadership: It's in Your DNA "Rhea Duttagupta examines how her interviewees became leaders, what worked for them, mistakes they've learned from and risks they've taken. From boardroom politics to the challenges faced by the first female commissioner of Asian police tasked with transforming the world's one of the most corrupt prisons, the stories are diverse, inspirational and instructional. This book provides readers with a framework of ten ingredients distilled from Rhea's extensive experience and research. She argues that these ingredients are innate within us and that if we recognise their importance and enhance them within ourselves, they'll help us maximise our achievements and our leadership qualities. ISBN:9781283902427 Author:Rhea Duttagupta

Brief Summary In this vital book, visionary international investment manager Antoine van Agtmael -- the pioneer who coined the term "emerging markets" -- pulls back the curtain on the new powerhouses of the world economy. Picking up where Thomas Friedman's The World Is Flat left off, he persuasively demonstrates that the world's center of gravity is already tipping decisively in favor of the emerging economies. With this seismic shift, competitive challenges and investment risks are also being dramatically transformed, while new opportunities are arising for those who are alert to them. A new breed of world-leading companies are catching their Western competitors off guard. Household names of today -- IBM, Ford, Sony, and Shell -- are in danger of becoming has-beens as these more innovative new superstars in the emerging markets claim dominance. Understanding how they have become world-class market leaders, and where they are taking the world economy, is crucial to understanding not only the future of globalization, but the future of Western competitiveness. Each year we are buying more planes from Brazil's Embraer, refrigerators from China's Haier appliance maker, smart cell phones from Taiwan's HTC, and gas from Russia's Gazprom. How have these relative unknowns come so far in the world markets so fast? What are they doing right that their Western competitors are doing wrong, and how can Western companies face the intensifying challenges and survive? With in-depth, inside knowledge of these emerging powerhouses that's based on his thirty years of working, traveling, and investing in emerging markets and his extraordinary access to the leading companies, van Agtmael trains his experienced analyst's eye on twenty-five of the top emerging giants, taking readers into the executive suites and labs where they are outmaneuvering their Western rivals. Profiling these major players, such as Korea's Samsung Electronics, China's computer maker Lenovo, Brazil's iron ore giant CVRD, and India's Infosys, van Agtmael divulges their strategies for growth, and analyzes how their rise to dominance will change our lives. His unique insights point the way to how we in the West can capitalize on the opportunities these companies represent while also mobilizing a powerful response to the challenges they present. The Emerging Markets Century is a compelling and necessary read for anyone who wants to understand the true magnitude of change under way in the global economy today. ISBN:9781847370303 Author:Antoine W van Agtmael

Brief Summary When it was announced in late 2000 that Jeff Immelt would be taking the helm of GE, some skeptics were quick to voice their reservations about the future of the company after Jack Welch. Not only were Welch's shoes particularly large ones to fill, but the economy was dallying with recession, China and India were taking their first giant steps into the global economy, and just four days into Immelt's tenure came the biggest game changer of all: 9/11. The hand-wringing, it turned out, was all for nought. During Immelt's first seven years on the job, GE's revenues increased by more than 60%, its profits doubled, and the company solidified its status as the world leader in technological innovation. Written with the full cooperation of Immelt and GE senior executives, Jeff Immelt and the New GE Way tells the amazing story of how Immelt defied the skeptics and successfully reengineered one of the world's oldest and largest global conglomerates to meet the challenges of the 21st century. It offers an unparalleled opportunity to learn how it's done from a master, detailing the trendsetting innovations Immelt pioneered that have made his vision a reality, including: • Mandating non-stop, company-wide innovation • Making customers partners in growth through Customer Dreaming Sessions • Developing region-specific products and services • Partnering with the most promising new-technology upstarts • Going green with a hugely successful Ecomagination initiative • Fostering a non-stop learning environment The critics were right: Jeff Immelt is no Jack Welch. Just as Welch embodied corporate leadership for the closing decades of the 20th century, Immelt has come to personify the 21st century CEO. As Esquire magazine said when it named him one of The 75 Most Important People of the 21st Century: "The day will come, when GE chairman and CEO, Jeff Immelt, will be viewed as the prototypical leader for the new century.” ISBN:9780071605885 Author:David Magee

Brief Summary The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley. " ISBN:9781524731656 Author:John Carreyrou